跳至主要内容
临床试验/NCT05959603
NCT05959603招募中3 期

Intra-wound Vancomycin Powder for Prevention of Surgical Site Infection Following Spinal Surgery - a Randomized Controlled Superiority Trial

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 363 人开始时间: 2020年5月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
入组人数
363
试验地点
1
主要终点
Incidence of deep spinal infections

研究概览

简要总结

Cefazolin is given routinely pre and intraoperatively for patients undergoing spinal surgery to reduce the rate of infection. Intra-wound admission of Vancomycin powder has been suggested to reduce wound infection rates. Therefore, this study aims to compare the rate of wound-related complications between patients receiving standard treatment compared to patients receiving an addition of topical Vancomycin and to identify the optimal Vancomycin dosage. All groups will receive the recommended regimen of routine IV antibiotic prophylaxis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing posterior spinal fusion operation at the neurosurgery department at the Rabin Medical Center
  • Ability to understand and sign written informed consent by the patient or legal guardian

排除标准

  • Preoperative ongoing infectious disease present as judged by the primary surgeon (based on lab results and clinical assessment)
  • Receiving ongoing treatment of antibiotics for other infections
  • Sensitivity or allergy to vancomycin or cefazolin
  • Previous spine surgery at the index level within the last 90 days
  • Postoperative radiotherapy of the surgical site required (e.g. for tumor)
  • Renal insufficiency with stage 4 chronic kidney disease (CKD) with a glomerular filtration rate (GFR) of 15-30 ml/min or worse
  • Undergoing spinal decompression only
  • Trauma patients
  • Pregnancy

研究组 & 干预措施

Intervention group: 500 mg vancomycin

Experimental

Patients will receive 500 mg of powdered vancomycin to the surgical site in addition to standard of care IV prophylaxis

干预措施: Vancomycin (Drug)

Intervention group: 1 g vancomycin

Experimental

Patients will receive one gram of powdered vancomycin to the surgical site in addition to standard of care IV prophylaxis

干预措施: Vancomycin (Drug)

结局指标

主要结局

Incidence of deep spinal infections

时间窗: One year

According to Center for Disease Control and Prevention (CDC) criteria

次要结局

  • Incidence of superficial spinal infections(One year)
  • Individual components of the composite primary outcomes(One year)
  • Rate of Surgical site infection revisions(30 days)
  • Number of adverse events(Up to one week post-surgery)
  • Length of hospitalization(From operation date to discharge (up to 4 weeks) or date of death)
  • Rate of mortality(One year)
  • Rate of post-operative seroma(30 days)
  • Concentration of creatinine (mg/dl), glucose (mg/dl) and albumin (g/dl)(Pre-operation, Post-operation Day 3, Post-operation Day 7, Post-operation Day 30)
  • Serum vancomycin levels(6 and 12 hours post op and then one test a day until vancomycin levels reach zero)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eyal Itshayek

Prof. Eyal Itshayek

Rabin Medical Center

研究点 (1)

Loading locations...

相似试验